Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  BNP Paribas    BNP   FR0000131104


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Risk haunts Societe Generale's Oudea in elusive hunt for growth

10/07/2020 | 02:18am EST
FILE PHOTO: The headquarter skyscraper offices of Societe Generale stand at the financial and business district of La Defense near Paris

PARIS (Reuters) - Frederic Oudea promised Societe Generale investors "growth with lower risk" after he became chief executive in 2008, the year a rogue trader lost billions in equity derivatives and brought the French bank close to collapse.

Fast forward a decade and SocGen's share price is at a record low and the bank's market capitalisation 78% lower than where it was when Oudea took over, after losses on complex investment products wiped out equity trading revenue in the first and second quarters of 2020.

"The current valuation of SocGen makes no sense," Oudea, whose term expires in 2023, told Reuters.

The bank's share price, which closed up 6.7% at 12.2 euros on Tuesday, gives it a market capitalisation of about 10 billion euros ($11.8 billion), around a quarter of that of rival BNP Paribas and half that of Credit Agricole.

Oudea has responded to the latest set-back by overhauling the top management at France's third-largest largest bank and is once again focused on delivering lower risk growth.

The 57-year-old Parisian says that a revamped markets unit, coupled with an end to the European Central Bank's ban on dividend payments, which limits how banks can reward their shareholders, and a restructuring of SocGen's retail business can reverse the situation.

"The situation should be very different in three or four quarters," Oudea, who is the longest-serving current CEO of a major European bank, said during a meeting at SocGen's modernist twin tower offices in the La Defense district of Paris.

"We have recently confirmed our guidance to deliver improved performances in the second half, in particular regarding our equity business, and have launched a promising study to create a new leading retail bank in France," he said.

In 2010, Oudea said lowering risk meant "significantly reducing market risk" and strengthening its risk department. He has since succeeded in bringing down SocGen's Value at Risk (VaR), a measure of its trading exposures or a maximum amount of daily losses that could happen with a 99% probability.

But while SocGen filings show its quarterly VaR fell to 23 million euros on average in 2019, from 25 million in 2013 and 35 million in 2010, this year's blow-out has left some investors and analysts uncertain whether Oudea is near to finishing the job.

"The two recent quarters were a vivid example that their business model is probably not as balanced or stable as they wanted it to be," Olivier Panis, credit rating analyst at Moody's, said of SocGen's recent results.

Oudea has spent much of his tenure trying to make earnings at the investment bank and group levels less reliant on selling investors complex structured products linked to equities.

But tighter capital rules made growth in other areas like fixed income difficult, with equity derivatives remaining the one niche it commanded a sizeable market share in.

"They had a problem with structured products in Q2, but it was not compensated by the rest of the investment bank. That made a big contrast with other French banks' results," Guillaume Brisset, a partner and a fund manager at Clartan Associés which holds SocGen shares, said.

Equity trading accounted for 29% of SocGen's investment bank revenue in 2019, and for 10% of the group's overall revenue. This compared with 17% of investment bank revenue and for 5% of group revenue at French rival BNP for the same year.

SocGen's equity trading revenue fell by 80% in the second quarter and was almost completely wiped out in the first, while JP Morgan and Goldman Sachs, the only two banks with bigger equity derivatives franchises according to Coalition data, both saw equity earnings surge.

But UBS analysts expect SocGen's equity trading revenue to rise by 20% in the third quarter, outperforming all of its peers, including BNP, JP Morgan and Goldman.

"Volatility remained elevated but without major spikes, typically a constructive environment for derivatives trading" UBS said in a note, adding that its top picks are Barclays and BNP, with SocGen its "least preferred" bank for European CIB (corporate and investment banking).


With limited chances of making traction in other areas of trading, Oudea is not planning to scale back equity derivatives. Instead he wants to sell the same amount of products in terms of billions of euros, but to focus on ones which carry less risk.

This means fewer of the products bearing exotic names that lost SocGen millions when companies cancelled dividends and stock prices tanked during the market sell-off in March.

SocGen will now offer alternative products where risks are easier to manage, but yields for investors will be lower.

"So we have already designed new products where ... we don't have this dividend risk," Oudea said during a banking conference last month, adding: "We will go probably for more single-asset products than products with correlation."

De-risking will only address part of the challenge which Oudea faces in his remaining years as CEO.

Oudea, who has been at the bank for 25 years, is credited with shoring up the capital base, its Achilles' heel after the 2008 crisis, and selling some non-core businesses.

Sources have also told Reuters that SocGen is gearing up for a sale of its asset management business Lyxor in a bid to cut costs. SocGen declined to comment on this.

While further asset sales and French retail restructuring will help on costs, they will do less to improve profit growth and scale and Oudea has said he would only take part in major deals as a buyer as European banking prepares for expected consolidation.

However, some investors say SocGen's options look limited.

"It is somewhat stuck because it is too small and has therefore no room for manoeuvre. Many of its activities are of a sub-optimal size," Brisset at Clartan Associés said.

(Reporting by Maya Nikolaeva; Editing by Rachel Armstrong and Alexander Smith)

By Maya Nikolaeva

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
BNP PARIBAS 1.06% 43.825 Real-time Quote.-17.05%
CRÉDIT AGRICOLE SA 0.37% 9.864 Real-time Quote.-23.68%
SOCIÉTÉ GÉNÉRALE 0.80% 17.328 Real-time Quote.-44.13%
All news about BNP PARIBAS
11/27BNP PARIBAS : Gets a Buy rating from RBC
11/27BNP PARIBAS : Notification by the ECB of the 2020 Supervisory Review and Evaluat..
11/26BNP PARIBAS : Isabelle Giordano will succeed Jean Jacques Goron as Head of Group..
11/24ANALYSIS : Carbon pricing rises as world's weapon of choice in climate fight
11/20BNP PARIBAS : UBS keeps its Buy rating
11/19BNP PARIBAS : 7th amendment to the 2019 Universal Registration Document
11/19BNP PARIBAS : Berenberg maintains a Sell rating
11/17Amundi and BNP vie for SocGen asset manager Lyxor - sources
11/17Saudi Aramco gets $8 billion with jumbo five-part bond deal
11/17Saudi Aramco gets $8 billion with jumbo five-part bond deal
More news
Sales 2020 44 351 M 53 057 M 53 057 M
Net income 2020 6 598 M 7 893 M 7 893 M
Net Debt 2020 - - -
P/E ratio 2020 8,58x
Yield 2020 5,39%
Capitalization 54 741 M 65 448 M 65 486 M
Capi. / Sales 2020 1,23x
Capi. / Sales 2021 1,23x
Nbr of Employees 198 816
Free-Float 86,5%
Duration : Period :
BNP Paribas Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BNP PARIBAS
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 46,09 €
Last Close Price 43,83 €
Spread / Highest target 40,1%
Spread / Average Target 5,16%
Spread / Lowest Target -31,8%
EPS Revisions
Jean-Laurent Bonnafé Chief Executive Officer & Director
Jean Lemierre Chairman
Philippe Bordenave Chief Operating Officer & Director
Denis Kessler Director
Jane Fields Wicker-Miurin Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BNP PARIBAS-17.05%65 448
HDFC BANK LIMITED12.15%107 171
US BANCORP-24.64%66 600
BANCO SANTANDER, S.A.-31.04%51 068
INTESA SANPAOLO S.P.A.-17.20%45 114